info@biomedres.us
+1 (502) 904-2126
One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA
Site Map
ISSN: 2574 -1241
ISSN: 2574 -1241
Received: March 25, 2018; Published: April 11, 2018
DOI: 10.26717/BJSTR.2018.03.000952
Back ground: Lacrimal gland adenocarcinoma is very rare tumor and highly agrressive.
Methods: A 86-year-old woman presented with a 5-month history of a painless mass in the right uppereyelid. The clinical presentation, workup, surgical approach, and pathological findings were reviewed.
Results: Incisional biopsy was performed toconfirm diagnosis. After histopathologicalconfirmation,exenteration was undergone and follows up further to oncology department.
Conclusion: Tumors of lacrimal gland are highly aggressive but fortunately are very rare. In invasive cases complete excision of tumor, or exenteration with adjuvant radiotherapy and chemotherapy is highly recommended.
Keywords: Lacrimal Gland; Adenocarcinoma NOS;Neoplasia; Exenteration
Abstract Introduction| Case Report| Discussion| Conclusion| References|
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China
Full Text
PDF
